📰 David Hung News
David Hung News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Hung. Real-time updates on events, politics, business and more.
April 24, 2024
Nuvation Bio Inc. , a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced...
April 20, 2024
Insider trading generally refers to the trading of a company’s security based upon material non-public information (“MNPI”) about that company. But a recent litigation victory by the...
April 10, 2024
10.04.2024 - Nuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the completion of the acquisition of ... Seite 1
April 2, 2024
MARKHAM, Ontario, April 02, 2024 -- Sienna Senior Living Inc. announced that it will report its 2024 first quarter results after market close on Thursday, May 9, 2024. Nitin Jain, President and...
March 28, 2024
Ms. Sjogren brings nearly 30 years of biopharmaceutical experience building commercial organizations and leading successful oncology launches Pending acquisition of AnHeart Therapeutics and...
March 25, 2024
Acquisition transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025 Acquisition adds taletrectinib, a next-generation,...
March 25, 2024
Nuvation Bio Inc. entered into an Agreement and Plan of Merger to acquire AnHeart Therapeutics Ltd. on March 24, 2024. Nuvation Bio entered into a definitive agreement for Nuvation Bio to acquire...
February 29, 2024
Determined maximum tolerated dose in Phase 1 monotherapy study of NUV-868; Phase 1b studies of NUV-868 in combination with olaparib or enzalutamide remain ongoing Received U.S. Food and Drug...
January 17, 2024
MARKHAM, Ontario, Jan. 17, 2024 -- Sienna Senior Living Inc. announced that it will report its 2023 fourth quarter results after market close on Tuesday, February 20, 2024. Nitin Jain, President...
January 8, 2024
Nuvation Bio Inc. , a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of...